Literature DB >> 26711869

Response.

Nicolas Wentzensen1, Barbara Fetterman2, Philip Castle2, Mark Schiffman2, Shannon Wood2, Diane Tokugawa2, Clara Bodelon2, Nancy Poitras2, Tom Lorey2, Walter Kinney2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26711869      PMCID： PMC4862437          DOI： 10.1093/jnci/djv390

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

2.  Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Authors:  Warner K Huh; Kevin A Ault; David Chelmow; Diane D Davey; Robert A Goulart; Francisco A Garcia; Walter K Kinney; L Stewart Massad; Edward J Mayeaux; Debbie Saslow; Mark Schiffman; Nicolas Wentzensen; Herschel W Lawson; Mark H Einstein
Journal:  J Low Genit Tract Dis       Date:  2015-04       Impact factor: 1.925

Review 3.  From differences in means between cases and controls to risk stratification: a business plan for biomarker development.

Authors:  Nicolas Wentzensen; Sholom Wacholder
Journal:  Cancer Discov       Date:  2013-01-08       Impact factor: 39.397

4.  p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.

Authors:  Nicolas Wentzensen; Barbara Fetterman; Philip E Castle; Mark Schiffman; Shannon N Wood; Eric Stiemerling; Diane Tokugawa; Clara Bodelon; Nancy Poitras; Thomas Lorey; Walter Kinney
Journal:  J Natl Cancer Inst       Date:  2015-09-15       Impact factor: 13.506

5.  Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.

Authors:  Julia C Gage; Mark Schiffman; Hormuzd A Katki; Philip E Castle; Barbara Fetterman; Nicolas Wentzensen; Nancy E Poitras; Thomas Lorey; Li C Cheung; Walter K Kinney
Journal:  J Natl Cancer Inst       Date:  2014-07-18       Impact factor: 13.506
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.